MUC1-C influences cell survival in lung adenocarcinoma Calu-3 cells after SARS-CoV-2 infection

키워드

참고문헌 (37)

1. Wu F, "A new coronavirus associated with human respiratory disease in China", Nature, 579, pp.265~269 (2020)
2. Zhou P, "A pneumonia outbreak associated with a new coronavirus of probable bat origin", Nature, 579, pp.270~273 (2020)
3. Richardson S, "Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area", JAMA, 323, pp.2052~2059 (2020)
4. Yu J, "SARS-CoV-2transmission in cancer patients of a tertiary hospital in Wuhan", JAMA Oncol, 6, pp.1108~1110 (2020)
5. Sidaway P, "COVID-19 and cancer : What we know so far", Nat Rev Clin Oncol, 17, pp.336~ (2020)
6. Bersanelli M, "Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors", Immunotherapy, 12, pp.269~273 (2020)
7. Siegel RL, "Cancer statistics, 2020", CA Cancer J Clin, 70, pp.7~30 (2020)
8. Russano M, "Coronavirus disease 2019 or lung cancer: What should we treat?", J Thorac Oncol, 15, pp.e105~e106 (2020)
9. Zhang H, "The treatment and outcome of a lung cancer patient infected with severe acute respiratory syndrome coronavirus-2", J Thorac Oncol, 15, pp.e63~e64 (2020)
10. Hollingsworth MA, "Mucins in cancer : protection and control of the cell surface", Nat Rev Cancer, 4, pp.45~60 (2004)
11. Levitin F, "The MUC1 SEA module is a self-cleaving domain", J Biol Chem, 280, pp.33374~33386 (2005)
12. Macao B, "Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin", Nat Struct Mol Biol, 13, pp.71~76 (2006)
13. Kufe DW, "Mucins in cancer : function, prognosis and therapy", Nat Rev Cancer, 9, pp.874~885 (2009)
14. Kufe DW, "MUC1-C oncoprotein as a target in breast cancer : activation of signaling pathways and therapeutic approaches", Oncogene, 32, pp.1073~1081 (2013)
15. Ahmad R, "MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop", Sci Signal, 4, pp.ra9~ (2011)
16. Huang L, "MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of betacatenin", Cancer Res, 65, pp.10413~10422 (2005)
17. Awaya H, "Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung", Am J Clin Pathol, 121, pp.644~653 (2004)
18. Kaira K, "MUC1expression in pulmonary metastatic tumors : a comparison of primary lung cancer", Pathol Oncol Res, 18, pp.439~447 (2012)
19. Xu M, "Critical roles of mucin-1 in sensitivity of lung cancer cells to tumor necrosis factoralpha and dexamethasone", Cell Biol Toxicol, 33, pp.361~371 (2017)
20. Lu W, "Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical Ill COVID‐19 patients", J Med Virol, 93, pp.582~584 (2021)
21. Park Byoung Kwon, "Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection", Biomolecules & Therapeutics, 29(3), pp.273~281 (2021), 한국응용약물학회[DOI]
22. Gao J, "MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion", Int J Oncol, 35, pp.337~345 (2009)
23. Lindén SK, "MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy", PLoS Pathog, 5, pp.e1000617~ (2009)
24. Thathiah A, "Tumor necrosis factor-alpha converting enzyme", ADAM 17 mediates MUC1shedding, 2003, pp.278, 3386~3394
25. Thathiah A, "Mt1-Mmp mediates muc1 shedding independent of tace", adam17, 2004, pp.382, 363~373
26. Nath S, "MUC1 : a multifaceted oncoprotein with a key role in cancer progression", Trends Mol Med, 20, pp.332~342 (2014)
27. Kaira K, "Depolarized MUC1 expression is closely associated with hypoxic markers and poor outcome in resected non–small cell lung cancer", Int J Surg Pathol, 20, pp.223~232 (2012)
28. Li Y, "Anti-inflammatory effect of MUC1 during respiratory syncytial virus infection of lung epithelial cells in vitro", Am J Physiol Lung Cell Mol Physiol, 298, pp.L558~L563 (2010)
29. Baños-Lara Mdel R, "Differential mucin expression by respiratory syncytial virus and human metapneumovirus infection in human epithelial cells", Mediators Inflamm, 2015, pp.347292~ (2015)
30. Luo J, "COVID-19 in patients with lung cancer", Ann Oncol, 31, pp.1386~1396 (2020)
31. Mahmoud Kandeel, "Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers", Biomolecules & Therapeutics, 28(4), pp.311~319 (2020), 한국응용약물학회[DOI]
32. 박병권, "Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex", BMB Reports, 52(6), pp.397~402 (2019), 생화학분자생물학회[DOI]
33. Raina D, "Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells", Cancer Res, 69, pp.5133~5141 (2009)
34. Min Jea Shin, "PEP-1-GLRX1 Protein Exhibits Anti-Inflammatory Effects by Inhibiting the Activation of MAPK and NF-κB Pathways in Raw 264.7 Cells", BMB Reports, 53(2), pp.106~111 (2020), 생화학분자생물학회[DOI]
35. Wu G, "A mucin1 C-terminal subunit-directed monoclonal antibody targets overexpressed mucin1 in breast cancer", Theranostics, 8, pp.78~91 (2018)
36. Wu G, "A novel monoclonal antibody targets mucin1 and attenuates growth in pancreatic cancer model", Int J Mol Sci, 19, pp.2004~ (2018)
37. Park BK, "MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein", Theranostics, 11, pp.3853~3867 (2021)

관련 논문AI추천